Glucotrack Announces New Addition to Medical Advisory Board
Glucotrack, Inc., a pioneer in medical devices tailored for diabetes care, has made an exciting announcement. The company has appointed Dr. Guillermo Umpierrez, a highly respected expert in the field of diabetes management, to its Medical Advisory Board. Dr. Umpierrez's appointment marks a significant step forward for Glucotrack, as it continues to advance its innovative Continuous Blood Glucose Monitoring (CBGM) technology.
Expertise in Diabetes Care
Dr. Umpierrez brings a wealth of knowledge and experience to Glucotrack. With his deep commitment to enhancing diabetes care, he has been instrumental in advancing clinical research in this vital area. His extensive background includes serving as a Professor of Medicine at Emory University and previously as the president of the American Diabetes Association for Medicine and Science. Under his leadership, numerous advances in diabetes treatment and understanding have emerged, particularly for hospitalized patients.
Contributions to Diabetes Research
Having published over 500 scientific manuscripts and book chapters, Dr. Umpierrez has made significant contributions to the academic and clinical dialogue surrounding diabetes. His recognition from various esteemed organizations, including the American College of Physicians and the American Association of Clinical Endocrinology, highlights his lasting impact on the field. He is board-certified in Internal Medicine and Endocrinology, further solidifying his expert status.
Glucotrack's Innovative Technology
Glucotrack's CBGM system is designed to revolutionize how blood glucose levels are monitored. Unlike traditional systems that often lag in responding to changes in glucose levels by measuring interstitial fluid, Glucotrack's technology aims to provide real-time accuracy in blood glucose level measurements. With a sensor life of three years and no need for a wearable component, this technology addresses many challenges currently faced by those living with diabetes.
Dr. Umpierrez’s Vision
In a recent statement, Dr. Umpierrez expressed his enthusiasm for joining Glucotrack's Medical Advisory Board. He acknowledged the significance of Glucotrack's continuous blood glucose monitoring technology and its potential to transform diabetes management. Eager to contribute to the clinical development of this promising technology, he highlighted the importance of innovation in improving the lives of diabetes patients.
Commitment to Continuous Improvement
As Glucotrack continues its mission to make glucose monitoring less burdensome, the insights and guidance from Dr. Umpierrez will be invaluable. His thought leadership will play a crucial role in evolving the company's technologies and strategies as they enter human clinical trials and beyond. The Medical Advisory Board, with Dr. Umpierrez at the helm, is poised to usher in new standards in diabetes care.
Why the Change Matters
In an industry where technological advancements can directly impact patient outcomes, the addition of experienced professionals like Dr. Umpierrez indicates Glucotrack's serious commitment to innovation. His involvement reassures stakeholders that the company is steering its resources towards developing effective solutions that could reshape the landscape of diabetes management.
About Glucotrack, Inc.
Glucotrack, Inc. focuses on designing and commercializing innovative technologies to aid people with diabetes. Their development of a long-term implantable continuous blood glucose monitoring system aims to provide uninterrupted monitoring and greater accuracy for individuals with diabetes. The unique features of Glucotrack's CBGM system not only enhance usability but also aim at improving the quality of life for those managing this chronic condition.
Frequently Asked Questions
What is Glucotrack's CBGM technology?
Glucotrack's CBGM technology is a continuous blood glucose monitoring system designed to provide real-time glucose level measurements without the lag associated with traditional methods.
Who is Dr. Guillermo Umpierrez?
Dr. Guillermo Umpierrez is a Professor of Medicine at Emory University and has extensive experience in diabetes care and research. He has published numerous academic papers and served as the past president of the American Diabetes Association for Medicine and Science.
How long does the CBGM sensor last?
The CBGM sensor from Glucotrack has a lifespan of three years, offering long-term continuous monitoring for patients.
What are the advantages of Glucotrack’s technology?
Glucotrack's technology aims to provide real-time accuracy, comfort without the need for a wearable component, and improved supply management in diabetes monitoring.
Why is Dr. Umpierrez's role important for Glucotrack?
His expertise and leadership will guide the clinical development of Glucotrack's technologies, helping the company to innovate and advance its solutions in diabetes care.
